Solid Biosciences (SLDB) Non-Current Assets (2017 - 2024)
Historic Non-Current Assets for Solid Biosciences (SLDB) over the last 8 years, with Q3 2024 value amounting to $32.3 million.
- Solid Biosciences' Non-Current Assets fell 1113.19% to $32.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was $32.3 million, marking a year-over-year decrease of 7889.91%. This contributed to the annual value of $35.2 million for FY2023, which is 1331.81% down from last year.
- Per Solid Biosciences' latest filing, its Non-Current Assets stood at $32.3 million for Q3 2024, which was down 1113.19% from $33.4 million recorded in Q2 2024.
- Over the past 5 years, Solid Biosciences' Non-Current Assets peaked at $40.6 million during Q4 2022, and registered a low of $8.9 million during Q1 2022.
- Its 5-year average for Non-Current Assets is $24.8 million, with a median of $32.3 million in 2024.
- In the last 5 years, Solid Biosciences' Non-Current Assets tumbled by 3159.37% in 2021 and then skyrocketed by 33567.28% in 2023.
- Quarter analysis of 5 years shows Solid Biosciences' Non-Current Assets stood at $12.3 million in 2020, then fell by 20.38% to $9.8 million in 2021, then surged by 315.79% to $40.6 million in 2022, then dropped by 13.32% to $35.2 million in 2023, then decreased by 8.16% to $32.3 million in 2024.
- Its Non-Current Assets stands at $32.3 million for Q3 2024, versus $33.4 million for Q2 2024 and $34.5 million for Q1 2024.